Sort
39,280 grants matching “leukemia”
Regulation of retinal angiogenesis and vascular integrity by the oxygen sensing mechanism
$487,107Guo-Hua Fong · University Of Connecticut Sch Of Med/Dnt · R01 · FY2019 · EY
Regulation of retinal angiogenesis and vascular integrity by the oxygen sensing mechanism
$487,107Guo-Hua Fong · University Of Connecticut Sch Of Med/Dnt · R01 · FY2017 · EY
Regulation of retinal angiogenesis and vascular integrity by the oxygen sensing mechanism
$487,107Guo-Hua Fong · University Of Connecticut Sch Of Med/Dnt · R01 · FY2016 · EY
Regulation of retinal angiogenesis and vascular integrity by the oxygen sensing mechanism
$487,107Guo-Hua Fong · University Of Connecticut Sch Of Med/Dnt · R01 · FY2015 · EY
Regulation of retinal angiogenesis and vascular integrity by the oxygen sensing mechanism
$487,107Guo-Hua Fong · University Of Connecticut Sch Of Med/Dnt · R01 · FY2018 · EY
Tuning CAR-T cell function
$487,050Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Tuning CAR-T cell function
$487,050Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
The role of Pleckstrin-2 as a functional node in myeloid proliferation
$486,783Peng Ji · Northwestern University At Chicago · R01 · FY2023 · HL
The role of Pleckstrin-2 as a functional node in myeloid proliferation
$486,783Peng Ji · Northwestern University At Chicago · R01 · FY2022 · HL
Functional analysis of the immune landscape in IDH mutant gliomas
$486,750Viviane Tabar · Sloan-Kettering Inst Can Research · R21 · FY2021 · NS
Mechanism of combined 'epigenetic therapy' in myeloid malignancies
$486,728Steven D Gore · Johns Hopkins University · R01 · FY2009 · CA
A Model System for Physiological Exocytosis
$486,719Fredric S Cohen · Rush University Medical Center · R01 · FY2006 · GM
Developing and credentialing patient-derived xenograft models to advance therapeutic approaches for chronic myelomonocytic leukemia
$486,704Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2023 · CA
Normal ABL1 kinase as tumor suppressor and therapeutic target in leukemia
$486,669Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2020 · CA
Normal ABL1 kinase as tumor suppressor and therapeutic target in leukemia
$486,669Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2021 · CA
Validation of Therapeutic Target Genes in Human Liver Cancer
$486,618Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
FANCD2 interaction with mismatch repair proteins and MCM2-7
$486,570Gary M. Kupfer · Yale University · R01 · FY2014 · HL
Targeting the Epigenome for Lung Cancer Therapy
$486,527David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
GENOMIC AND IMMUNOMIC MECHANISMS OF RESISTANCE DURING DARATUMUMAB POST STEM CELL TRANSPLANTATION IN PATIENTS WITH POOR-RISK T CELL LYMPHOBLASTIC LYMPHOMA LEUKEMIA
$486,472Regents Of The University Of California, San Francisco, The · · FY2025 · Defense Health Agency
Next Generation gene discovery in neurogenetics
$486,320Wendy H Raskind · University Of Washington · R01 · FY2019 · NS
Tumor cell metabolism in action
$486,290Eileen White · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA
Cell-targeted glutamine antagonists as a novel therapy for lymphoma
$486,249Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2022 · CA
Regulation of Normal and Pathogenic B Cell Proliferation by a c-Myc-initiated Transcription Factor Cascade
$486,196Takeshi Egawa · Washington University · R01 · FY2019 · AI
Bay Area Tumor Institute CCOP
$486,165James Feusner · Bay Area Tumor Institute · U10 · FY2012 · CA
Characterizing noncoding GWAS variants in acute lymphoblastic leukemia treatment outcome
$486,113Daniel Savic · St. Jude Children'S Research Hospital · R01 · FY2021 · CA